Author:
Levy Cynthia,Lymp James,Angulo Paul,Gores Gregory J.,Larusso Nicholas,Lindor Keith D.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference22 articles.
1. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Thursz MR, Wasan H: Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51(Suppl 6):VI1–VI9, 2002
2. Patel T: Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33(6):1353–1357, 2001
3. Chapman RW: Risk factors for biliary tract carcinogenesis. Ann Oncol 10(Suppl 4):308–311, 1999
4. Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, Jr, LaRusso NF: Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 213(1):21–25, 1991
5. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindberg G: Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38(4):610–615, 1996
Cited by
292 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent Advancement in Diagnosis of Biliary Tract Cancer through Pathological and Molecular Classifications;Cancers;2024-05-01
2. Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT);European Journal of Cancer;2024-05
3. Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy;Postgraduate Medicine;2024-04-02
4. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2;International Journal of Clinical Oncology;2024-03-17
5. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma;World Journal of Gastroenterology;2024-03-07